Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 ...
The Red Devil Chemo: Tips for Managing Side Effects
Chemotherapy Protocol
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
Phase 2 Study of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Eribulin Mesylate With or Without Prophylactic Growth Factor for Adjuvant Treatment of Early-Stage Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer -
Four cycles of docetaxel and cyclophosphamide as adjuvant chemotherapy in node negative breast cancer: A real-world study - ScienceDirect
Dose-dense chemotherapy for breast cancer: what does the future hold? | Future Oncology
Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial - The Lancet Regional Health – Western Pacific
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
Standardizing Chemotherapy Regimen Nomenclature: A Proposal and Evaluation of the HemOnc and National Cancer Institute Thesaurus Regimen Content | JCO Clinical Cancer Informatics
Chemotherapy for Uterus Cancer
Neoadjuvant Chemotherapy Considerations in Triple-Negative Breast Cancer
Chemotherapy protocol definition form | Download Scientific Diagram
Optimizing Adjuvant Chemotherapy in Early-Stage Breast Cancer
National Surgical Adjuvant Breast and Bowel Project (NSABP)
Pegylated liposomal doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy in locally advanced breast cancer (registration number: ChiCTR1900023052) | Scientific Reports
Frontiers | Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
Cancers | Free Full-Text | Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
Pregnancy-Associated Breast Cancer
Pocket Guide to Chemotherapy Protocols: 9781449646813: Medicine & Health Science Books @ Amazon.com
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
Adjuvant systemic therapy for HER2-positive breast cancer - UpToDate
